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Background: Obese patients with established coronary artery disease have reduced mortality
compared to normal or low body mass index (BMI) patients. The reason for the relation is not
yet clearly understood. We sought to evaluate the association of BMI and waist circumfer-
ence (WC) at the time of presentation in patients with myocardial infarction (MI) with one-
year adverse cardiac events.
Methods: In this prospective cohort study, we included consecutive patients with acute MI
admitted to a tertiary care hospital during a period of one year. Upon admission, BMI and WC
were measured. Patients were followed-up for a period of one year and the primary
composite outcome of death or non-fatal MI was correlated with BMI and WC categories.
Results: There were 703 patients (males 559 (79.5%)). Combined non-fatal MI and death at
one year was 128 (18.2%). Incidence of primary outcome was 25.0% in low BMI group, 19.9% in
normal BMI group, 13.1% in overweight group, 13.4% in class I obese, and 11.1% in class II
obese groups. In univariate analysis, the inverse correlation was signiﬁcant (p value = 0.007).
In one-year follow-up period, 12.8% in high and 20.8% in normal WC groups had primary
outcome (p value = 0.01). Both BMI and WC lost their predictive value in multivariate
analysis.
Conclusions: Low BMI and normal WC were associated with a worse short-term outcome in
patients with acute MI. Neither BMI nor WC independently predicted cardiac events or death
after acute MI.
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Obesity, which is established as a risk factor for the
development of cardiovascular diseases, has assumed epi-
demic proportions globally in adults as well as in children.
Body mass index (BMI) is the most accepted parameter for the
deﬁnition and categorization of obesity. Based on BMI, an
individual is classiﬁed as underweight (BMI <18.5 kg/m2),
normal (18.5–22.9 kg/m2), overweight (23–24.9 kg/m2), class I
obese (25–29.9 kg/m2), or class II obese (>30 kg/m2).1 Excess
abdominal fat deposition is established as a cardiovascular
risk factor over and above the general obesity. Waist
circumference (WC) is an accepted parameter for measuring
this abdominal obesity. High WC is deﬁned as WC greater than
90 cm in men and 80 cm in women.1
Because of its maladaptive effects on various cardiovascu-
lar risk factors and its adverse effects on cardiovascular
structure and function, obesity has a major impact on
cardiovascular diseases, such as coronary artery diseases
(CAD),2 heart failure (HF),3 sudden cardiac death,4 and atrial
ﬁbrillation,5 and is associated with reduced overall survival.
Based on these observations, virtually all national and
international guidelines recommend weight loss for over-
weight and obese patients for the primary and secondary
prevention of cardiovascular disease.6,7
Although obesity is clearly a risk factor for developing
CAD and HF, in patients in whom these diseases are
established, obesity is reported to have an inverse correlation
with all-cause mortality,8 cardiovascular mortality,9 and
need for repeat revascularization.10 It was found that obese
patients with established CAD had reduced mortality
compared with normal BMI patients, whether treated
medically, by percutaneous coronary intervention (PCI) or
by coronary artery bypass surgery (CABG). The highest
mortality rates are observed in patients with a very low
BMI (<18.5 kg/m2). This observation has been referred to as
the 'obesity paradox'.10,11 Though there are several studies
related to obesity paradox, the reason for the paradoxical U-
or J-shaped relation between BMI and adverse outcome is not
yet understood. Several explanations have been suggested
for this phenomenon.
Most of the previous studies on obesity paradox are
retrospective in nature. BMI was the most commonly used
epidemiological measure of obesity in these studies. It does
not directly distinguish between central from peripheral
adiposity.12 Other indices having better predictive power,
but less commonly used, include WC, waist-to-hip ratio, and
weight-to-height ratio.13 There are scant data published on
paradoxical relation of obesity and CAD, particularly in
patients with acute coronary syndromes from India.
2. Methods
In this prospective cohort study, patients admitted to
cardiology department of a tertiary hospital with a diagnosis
of acute ST elevation myocardial infarction (STEMI) or acute
non-ST elevation myocardial infarction (NSTEMI) were includ-
ed. ST-elevation MI and NSTEMI were deﬁned according toAmerican College of Cardiology Foundation/American Heart
Association (ACCF/AHA) guidelines.14,15
Exclusion criteria were history of myocardial infarction
(MI) in the last six months, severe valvular heart disease,
conditions where anthropometric measurements were not
possible and severe non-cardiac illness limiting survival to less
than one year.
BaselinedatawerecollectedregardingconventionalCADrisk
factors (diabetes mellitus, hypertension, smoking, and dyslipi-
demia), ECG manifestations, biochemical values, Thrombolysis
in myocardial infarction (TIMI) score, and Killip class at
presentation. Overnight fasting blood samples were collected
on the morning after admission for blood lipid and blood sugar
measurements. Detailsof reperfusionprocedures(thrombolysis
or PCI) were noted. Details of pre-discharge coronary angiogram
(CAG) and revascularization, if any, were recorded.
Anthropometric parameters were measured during admis-
sion to hospital. Height was measured by wall-mounted tape
to the nearest centimeter. Subjects were asked to stand
upright without shoes, with their back against the wall, heels
together, and eyes directed forward. Weight was measured
with portable weighing scale kept on a ﬁrm horizontal surface.
The subjects were asked to wear light clothing and remove
footwear. Weight was recorded to the nearest kilogram. WC
was measured using a non-stretchable measuring tape. The
subjects were asked to stand erect in a relaxed position with
both feet together. Waist girth was measured at the midpoint
between the iliac crest and the lower margin of the ribs at the
end of expiration, to the nearest centimeter. Patients were
categorized into BMI and WC groups according to WHO
Classiﬁcation of BMI and WC in Asian adults.16
Follow-up was done at one month, three months, six
months, and one year after discharge. Follow-up was
performed either in special clinic conducted for study or by
telephonic interview. Patients who report events over phone
were called to special clinic for veriﬁcation of records.
Primary outcome was a composite of death due to any
cause or non-fatal MI at one year. Secondary outcome was in-
hospital mortality. BMI and WC at admission were correlated
with both primary and secondary outcomes.
Statistical analysis was performed using Statistical Package
for Social Science software (SPSS Inc Chicago, Illinois version
18). Qualitative variables, expressed as numbers and percents,
were compared by the Chi-square test. We used univariate
analysis to determine the effect of factors affecting one-year
outcomes. Factors that were signiﬁcant predictors of outcomes
were used as independent variables in multiple logistic
regression analysis to determine independent predictors of
one-year outcome. A p-value of less than 0.05 was considered
as statistically signiﬁcant.
3. Results
There were 703 patients (males 559 (79.5%), females 144
(20.4%)). Of the total group, 100 (14.2%) were underweight, 351
(49.9%) were of normal weight, and 122 (17.3%) were
overweight. Class I obesity was seen in 112 (15.9%) and class
II obesity in 18 (2.5%) patients (Table 1). High WC was measured
in 227 (32%) among a total of 703 patients.
Table 1 – Patient categorization according to BMI.
BMI groups Number (%)
Total 703
Underweight (BMI1) 100 (14.2)
Normal weight (BMI2) 351 (49.9)
Overweight (BMI3) 122 (17.3)
Obese class I (BMI4) 112 (15.9)
Obese class II (BMI5) 22 (3.12)
BMI, body mass index.
Fig. 1 – Correlation of body mass index categories and
primary outcome (death or non-fatal myocardial infarction
at one year). Underweight (BMI1), Normal weight (BMI2),
Overweight (BMI3), Obese class I (BMI4) and Obese class II
(BMI5).
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summarized in Table 2. There were statistically signiﬁcant
differences in age, TIMI score at admission, ejection fraction,
and lipid values at admission. Patients in low BMI groups were
older and were having higher TIMI score and lower ejection
fraction, while there was a trend of higher lipid values among
patients in higher BMI groups. The baseline characteristics
were comparable between subgroups of patients with high or
normal WC.
3.1. BMI and outcomes
At one year, there were 40 (5.6%) deaths including 18 in-
hospital deaths. The incidence of primary outcome was 128
(18.2%). At one-year follow-up, 25.0% of low BMI group, 19.9%
of normal BMI group, 13.1% of overweight group, 13.4% of class
I obese group, and 11.1% of class II obese group had the
composite primary outcome. In univariate analysis, the
inverse correlation of obesity and primary outcome was
signiﬁcant by linear-by-linear association (p value = 0.007)
(Fig. 1 and Table 3). In-hospital mortality alone showed no
signiﬁcant trend among BMI groups.
Subgroup analysis was also done to ﬁnd out whether any
difference exists regarding the effect of BMI and the primary
outcome between the subgroups formed on the basis of sex,
diabetes mellitus, and hypertension. When separately ana-
lyzed, no correlation could be observed between BMI and the
primary outcome in any of the subgroups probably due to
smaller sample sizes in each of the subgroup (Table 6).Table 2 – Baseline characteristics of BMI subgroups.
BMI1 BMI2 
Age, mean (SD) 58.69 (9.3) 56.68 (11.2) 52
Diabetes% 26 28.2 34
Past history CVA% 4 3 4
Old CAD% 10 8.5 12
Dyslipidemia% 17 23.3 28
Hypertension% 31 35.8 37
Smoking% 55 59.5 59
TIMI average 2.68 2.82 2
Primary PCI% 6.5 7.6 10
LVEF% 54 58 59
Serum cholesterol 176 186 188
Serum triglycerides 107 114 118
PCI in 1 year 37 38.1 32
SD, standard deviation; LVEF, left ventricular ejection fraction; PCI, percu
Underweight (BMI1), Normal weight (BMI2), Overweight (BMI3), Obese cla
a Linear-by-linear association value.3.2. WC and outcomes
At one-year follow-up 12.8% in high WC group and 20.8% in
normal WC group had the composite primary outcome (p
value = 0.01) (Table 4). Secondary outcome of in-hospital
mortality was 0.9% in high WC group and 3.4% in normal
WC group ( p value = 0.052).
Other parameters, which were found to be predictive of one
-year outcomes, were age, TIMI risk score, and Killip class at
admission. But on multivariate analysis, none of these
parameters were found to have signiﬁcant predictive value
for the primary outcome (Table 5).
4. Discussion
Metabolic cardiovascular risk factors continuously worsen
with increasing BMI, which is described in many previous
studies.17–20 Our study showed an increasing trend for
incidence of dyslipidemia toward higher BMI subgroups.BMI3 BMI4 BMI5 p-Value
.98 (10.7) 54.92 (11.1) 52.78 (9.3) 0.001
.4 34.8 33.33 0.440
.9 8.03 0 0.322
.2 11.6 16.66 0.606
.6 30.3 22.22 0.031a
.7 30.32 16.66 0.769
.8 50 50 0.663
.40 2.49 1.83 0.037
.5 3.9 0 0.475
 60 58 <0.001
 189 173 0.183
 124 127 0.092
.78 30.3 27.7 0.501
taneous coronary intervention; CVA, cerebrovascular accident.
ss I (BMI4) and Obese class II (BMI5).
Table 5 – Multivariate analysis of primary outcome.
p-Value Adjusted ORa 95% CI for
OR
Lower Upper
BMI 0.756
BMI1 vs 2 0.310 0.757 0.443 1.296
BMI1 vs 3 0.207 0.618 0.293 1.304
BMI1 vs 4 0.283 0.643 0.287 1.440
BMI1 vs 5 0.621 0.663 0.130 3.390
Waist circumference 0.130 1.526 0.884 2.634
OR, odds ratio.
a After adjusting age, TIMI class, creatinine at admission, KILLIP
class at admission, Reference category BMI 1.
Table 3 – BMI and primary outcome (death or non-fatal MI
at 1 year).
BMI category Number (%) p-Value
Total 128 (18.2%)
Underweight 25 (25.0%) Linear-by-linear association
value (chi-square value for
trend)
0.007
Normal weight 70 (19.9%)
Overweight 16 (13.1%)
Obese class I 15 (13.4%)
Obese class II 2 (11.1%)
BMI, body mass index.
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ship between BMI and outcomes after acute MI. But after
multivariate analysis, these associations were found non-
signiﬁcant, which is consistent with most of the previous
studies from different parts of the world.19–21 Study of the
relation between BMI, WC, and death after acute MI by Zeller
et al. included 2229 consecutive patients with acute MI.19
Patients were classiﬁed according to BMI and WC. Increased
BMI was associated with a reduced death rate, with a 5% risk
reduction for each unit increase in BMI. WC as a continuous
variable had no impact on all-cause death. A combination of
decreased muscle mass and increased abdominal adiposity,
which may be termed sarcopenic obesity, which supposedly
elevates mortality risk in CAD, was identiﬁed in their study
population. Such a group was not identiﬁed in our sample. The
primary outcome in that study was cardiovascular mortality.
We could not keep cardiovascular mortality as the primary
outcome due to small sample size. After adjustment for
baseline predictors of death, neither BMI nor WC was an
independent predictor of death after acute MI. Inverse
relationship between BMI and outcomes was found due to
confounding factors interfering with survival, as seen in our
study.
A major impact of younger age in the apparent protection
conferred by obesity has been reported in many studies.22,23 As
obese patients with acute coronary syndromes are younger,
they are more likely to be referred to experts for secondary
prevention, to receive treatment for co-morbidities, a more
aggressive lifestyle modiﬁcation, and optimization of medical
treatment. This may be a plausible reason for the enhanced
survival in such individuals. In the present study population
also, age was signiﬁcantly lower in the higher BMI group
patients, which could have contributed to the better outcome.
A study on ‘‘obesity paradox’’ in Korean patients undergo-
ing primary PCI in STEMI by Kang et al. was recentlyTable 4 – Waist circumference and primary outcome
(death or non-fatal MI at 1 year).
Waist circumference
category
Number (%) p-Value
Total 128 (18.2%)
High waist circumference 29 (12.8%) 0.010
Normal waist circumference 99 (20.8%)
MI, myocardial infarction.published.20 Three thousand eight hundred and twenty-four
STEMI patients from Korean Acute MI Registry who underwent
primary PCI were selected. They were divided into four groups
according to BMI. In-hospital mortality, revascularization at
one year, mortality at one year and overall mortality were
compared. Obese patients had signiﬁcantly lower in-hospital
and overall mortalities. But obesity was not an independent
predictor of overall mortality after multivariate analysis.
Overweight and obese groups were signiﬁcantly younger,
had better LVEF, and were more likely to be men with a higher
incidence of hypertension, diabetes, and hyperlipidemia.
Obese STEMI patients treated by primary PCI were associated
with lower mortality, which was explained by younger age,
hemodynamic stability at admission, and better use of medical
treatment. In present study population also, LVEF was
signiﬁcantly low and TIMI score was signiﬁcantly high in
the lower BMI groups. The size of the coronary arteries
increases with increasing BMI, and small size of the vessels is a
risk factor for worse outcome after PCI and CABG.24 This study
did not look into this aspect.
In the present study, a worse outcome was observed in
patients with low WC. But most of the previous studies
showed worse outcome in patients with high WC along with
normal or low BMI, which presumably reﬂects the presence of
visceral obesity with low muscle mass and a lack of functional
subcutaneous adipose tissue.19 Functional adipose tissue
produces hormones that may have cardio-protective effects
in MI.25Table 6 – BMI and primary outcome: subgroup analysis.
Underweight Overweight Obese
Relative risk (95% CI)
Male 1.30 (0.82–2.07 0.56 (0.30–1.02) 0.68 (0.39–1.16)
Female 1.12 (0.50–2.48) 1.09 (0.44–2.68) 0.57 (0.18–1.83)
Diabetic 1.73 (0.94–3.19) 0.54 (0.22–1.32) 0.80 (0.39–1.66)
Non-diabetic 1.06 (0.63–1.79) 0.72 (0.39–1.32) 0.56 (0.29–1.08)
Hypertensive 1.40 (0.77–2.56) 0.19 (0.05–0.76) 0.41 (0.16–1.11)
Non-
hypertensive
1.19 (0.71–2.02) 0.01 (0.58–1.75) 0.81 (0.46–1.44)
All comparisons are against the group with normal BMI.
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There are signiﬁcantly large number of males in the study group
compared to females. This might have affected the results.
Similarly, there were signiﬁcant differences between the study
groups with reference to age, dyslipidemia, hypertension and
ejection fraction, which might have acted as confounding
factors. We did not have data on cause-speciﬁc mortality mainly
due to small sample size and relatively short follow-up
duration. 15% of the patients had missing data. These patients
would have had higher number of events, and therefore, their
exclusion from the analysis might have produced biased results.
We did not have prior sample size estimation, and hence, the
absence of correlation between BMI and outcomes on multivar-
iate analysis cannot be taken as a deﬁnitive result. Larger
studies are required for deﬁnite evidence.
5. Conclusion
Low BMI and normal WC are associated with a worse short-
term outcome in patients with acute MI. After adjusting for
other variables, neither BMI nor WC independently predicts
cardiac events or death after acute MI.
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